📖
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
Peyrl, Andreas, Chocholous, Monika, Sabel, Magnus, Štěrba, Jaroslav, LEBLOND, Pierre, Nysom, Karsten, Torsvik, Ingrid Kristin, Chi, Susan, André, Nicolas

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial

Science & Mathematics Published 2023 397.2 KB Verification Pending
Advertisement
SPONSOR CONTENT
Indexed from repository: Zenodo (zenodo.org)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
Author / Organization Peyrl, Andreas, Chocholous, Monika, Sabel, Magnus, Štěrba, Jaroslav, LEBLOND, Pierre, Nysom, Karsten, Torsvik, Ingrid Kristin, Chi, Susan, André, Nicolas
Subject & Discipline Scientific Research & Data
Categories Science & Mathematics
Publication Year 2023
License / Rights cc-by-4.0
Resource Verification Listed PDF (Verification Pending)
Original Host Website Zenodo (zenodo.org)
File Format application/pdf (Portable Document Format)
Reported File Size 397.2 KB (406,776 bytes)
Language EN
Catalog ID DOC-79135
Original Source Link Visit Source Page on zenodo.org »